Chandler Park

Last updated

Chandler Park
ChandlerPark.jpg
Education Biomedical engineering B.S. at (University of Illinois at Urbana-Champaign)
Medical Doctorate M.D. at (University of Louisville School of Medicine)
biophysics MSc (University of Louisville Graduate School)
Transitional surgery internship at Cleveland Clinic Foundation Health Systems
diagnostic radiology and internal medicine residency at Indiana University School of Medicine
Occupation(s)Physician, clinical researcher, medical writer

Chandler Park is an American physician, medical journalist, and clinical researcher. [1] In June 2021, his cancer research was published in prominent medical journals including the New England Journal of Medicine [2] and Journal of Clinical Oncology. [3] Park also contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek , [4] Reader's Digest , [5] [6] [7] U.S. News & World Report , [8] The Exponent-Telegram , [9] College of St. Scholastica , [10] and Medscape [11] and writes medical news for Doximity. [12] [13]

Contents

Career

Park is a clinical professor that teaches biochemistry, physiology, hematology, and medical oncology at the University of Louisville School of Medicine. [14] He also works as an advisory Dean at the University of Louisville School of Medicine and plays a vital role in the transition into medical school and the development into a physician. [15] Park was selected as a teaching faculty to provide new cancer information at American Society of Clinical Oncology. [16] In February 2019, he helped develop the continuing medical education course titled 2019 Breast and Gynecologic Cancers for American Society of Clinical Oncology [17] and published his continuing medical education course in Anticancer Therapeutics, Research, and Supportive Care. [18] In February 2020, he also helped develop a new continuing medical education online course for cancer physicians in America to update them on new cancer information in Hematologic Malignancies and Blood Cancers. [19] In June 2020, he was interviewed to discuss CAR-T Cell and provided information on upcoming treatments for CAR-T cell. [20]

Park is also one of the contributing authors of the book, Lung Cancer: Standards of Care [21] that discusses diagnosis and treatment of lung cancers released in December 2020. [22] Park was also interviewed by Targeted Oncology on Kidney Cancer Treatments in February 2021. [23]

In 2020, Park was selected as the President of the Kentucky Society of Clinical Oncology. [24] The Kentucky Society of Clinical Oncology is the state affiliate of American Society of Clinical Oncology, American Society of Hematology, and National Cancer Institute.

He has been interviewed by leading cancer media digital media including Cure Magazine, [25] [26] Targeted Oncology, [27] [28] Urology Times, [29] and OncLive [30] [31] [32] in 2023.

Journalism

Park writes medical columns for Medscape [33] and Doximity Op(m)ed. [34] He writes articles on medical education and cancer news. [35] His medical education writings include The Hidden Curriculum: How to Avoid Being Labeled a Problem Resident. [36] He has also written cancer news at the American Society of Clinical Oncology and American Society of Hematology annual meetings, [37] [38] [39] and has volunteered on the editorial board of Journal of Hospital Practice and helps select cancer journal articles for hospital physicians. [40] Park is the founder of Cancervisit a company dedicated to helping cancer patients and their families. [41] In April 2020, Park was interviewed by the American College of Physicians on ways medical students can prepare for residency training. [42]

Park also provides video medical updates for physicians on IMDb [43] and YouTube. [44] He has written cancer updates in kidney cancer with Toni Choueiri, [45] prostate cancer with Neeraj Agarwal, [46] and Bladder Cancer with Petros Grivas [47]

Education

Park received a Bachelor of Science degree in Biomedical Engineering and Biochemistry from University of Illinois at Urbana-Champaign and his Doctor of Medicine degree from the University of Louisville School of Medicine. He also acquired medical science research training at the University of Louisville in Louisville, Kentucky and received a master's degree in science in biophysics.

After his medical school and graduate school research training, Park served his surgery transitional internship at Cleveland Clinic Foundation Health Systems. Next, he did his residency training in diagnostic radiology and internal medicine at IU Medical Center. Afterwards he finished subspecialist medical training in Hematology and Oncology at WVU Cancer Institute and received additional medical training as a visiting fellow at University of Pittsburgh in cancer immunotherapy. [48]

He is a practicing cancer physician at Norton Cancer Institute and a physician member of the molecular tumor board at the University of Kentucky Markey Cancer Center. [49] Park is triple-board-certified in internal medicine, hematology and oncology. [50]

Research

Park has participated in multiple cancer clinical trials in lung, melanoma, thyroid, and bone marrow transplant. He has been nationally recognized as an exceptional doctor by his physician colleagues and was given an honorary title as a distinguished fellow of the American College of Physicians (FACP) for providing outstanding patient care and significant medical research contributions. [51]

Park has written cancer papers about PET/CT and regional brain metabolic changes associated with depression in metastatic breast cancer, [52] sorafenib and thyroid cancer, [53] pemetrexed-based chemotherapy in lung cancer, [54] atypical neurolymphomatosis, [55] metformin use and allogenic stem cell transplant, [56] and decreased cancer rates. [57]

Park's medical research also included an MRI study that used viscoelastic pads to improve patient care during MRI studies. His research group developed the patented viscoelastic pads used by many of the current MRI tables. [58] The viscoelastic pads decrease ischemia, pain, and discomfort for patients undergoing MRI studies. His MRI research led to improved quality of the MRI imaging studies to improve patient care, [59] He has also studied the effect of nicotine on bone arteriole blood flow. [60]

He also volunteers on the editorial board of Journal of Hospital Practice and helps select cancer journal articles for hospital physicians. [61]

Public speaking

After his landmark MRI study was published, Park has been a live public speaker at large medical society meetings including American Society for Therapeutic Radiology and Oncology, and Radiological Society of North America. [62] He was invited as a speaker to discuss "Designing Continuing Professional Development that improves patients care: Insights from a Practicing Oncologist" at the annual Alliance for Continuing Education meeting in Orlando, Florida. [63] In July 2018, he was interviewed by healthcare industry leading magazine Managed Health Care Executive on Five Ways Health Execs Can improve Lymphoma Treatment. [64]

In January 2020, he gave a live oral presentation to the Alliance of Continuing Medical Education for Healthcare Providers to improve cancer care by medical oncologists by discussing the importance of shared decision making with physicians, patients, nurses, patients' families, pharmacists, and the entire clinical care team. [65] He also co-hosted a medical education program for the Society for Immunotherapy of Cancer that discussed Advances in Cancer Immunotherapy on December 10, 2020. [66]

Park has been chosen as a Castle Connolly Top Doctor [67] in Cancer by his physician peers in 2019, [68] 2020, [69] and 2021. [70] In 2021, Park was recognized as one of the 3 best oncologists in Louisville, Kentucky by Three Best Rated. [71]

Park has also been recognized by the American Registry company with patient care awards in Patient's choice [72] and Compassionate Doctor. [73] In June 2020, he received the 5 year Patient's Choice award as one of Kentucky's Favorite Physicians [74] and top 1% of America's Most Honored Doctors. [75]

Authored works

Related Research Articles

A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.

Nicholas J. Vogelzang was a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN). He serves as medical director of the Research Executive Committee and Associate Chair of the Developmental Therapeutics and Genitourinary Committees for US Oncology Research. His research interests include clinical trials for genitourinary malignancies and mesothelioma.

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

<span class="mw-page-title-main">Oncology</span> Branch of medicine dealing with, or specializing in, cancer

Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:

<span class="mw-page-title-main">David Agus</span> English scientist, American physician, Professor of Medicine and Engineering and author

David B. Agus is an American physician, cancer researcher and author who serves as a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and the Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine. He is also the cofounder of several personalized medicine companies and a contributor to CBS News on health topics. He is also the author of four books.

<span class="mw-page-title-main">Tower Cancer Research Foundation</span>

Tower Cancer Research Foundation (TCRF) is a 501(c)(3) non-profit organization dedicated to clinical research, patient support and community education. It was established in 1996 in Beverly Hills, California.

<span class="mw-page-title-main">Wolfram Samlowski</span> Oncologist

Wolfram Samlowski is an American medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN) and a member of the Research Developmental Therapeutics and Genitourinary Committees for US Oncology. His research interests include translational research and development of novel cancer immunotherapy agents, translational drug development as well as gene therapy. His clinical interests are in developing more effective treatments for advanced stages of melanoma and non-melanoma skin cancers, and renal cancer.

Dr. Cora Sternberg is an American medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital, serving as a member of the Genitourinary (GU) Oncology Program. Dr. Sternberg facilitates the continued growth and development of clinical and translational research programs in GU malignancies. Dr. Sternberg is an internationally respected leader in the field of medical oncology and urological malignancies and a recognized expert in the area of new drug development. She is known for her seminal contributions in bladder cancer, her strong track record of sustained genito-urinary (GU) oncology leadership and collaboration in multiple practice-changing clinical trials, including novel medicines, and her current role applying her expertise in oncology and GU cancers to precision medicine to further improve outcomes for patients. Dr. Sternberg has been decidedly influential in the development of novel hormonal therapies and checkpoint inhibitors across the landscape of GU oncology as evidenced in her curriculum vitae. She is a globally respected researcher who has lectured extensively at universities and cancer symposia worldwide (>800). As Clinical Director of the Englander Institute for Precision Medicine (EIPM), Dr. Sternberg develops strategies to incorporate genomic sequencing and precision medicine throughout the Weill Cornell Medicine and NewYork-Presbyterian healthcare network, including Lower Manhattan, Brooklyn and Queens.

High-dose chemotherapy and bone marrow transplant (HDC/BMT), also high-dose chemotherapy with autologous bone marrow transplant, was an ineffective treatment regimen for metastatic breast cancer, and later high-risk breast cancer, that was considered promising during the 1980s and 1990s. With an overall idea that more is better, this process involved taking cells from the person's bone marrow to store in a lab, then to give such high doses of chemotherapy drugs that the remaining bone marrow was destroyed, and then to inject the cells taken earlier back into the body as replacement. It was ultimately determined to be no more effective than normal treatment, and to have significantly higher side effects, including treatment-related death.

<span class="mw-page-title-main">Seattle Cancer Care Alliance</span> Cancer treatment and research center in Seattle, U.S.

Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.

Ashok K. Vaid is an Indian medical oncologist, known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.

<span class="mw-page-title-main">Jimmie C. Holland</span> American psychiatrist

Jimmie Coker Holland was a founder of the field of psycho-oncology. In 1977, she worked with two colleagues to establish a full-time psychiatric service at Memorial Sloan Kettering Cancer Center. The program was one of the first of its kind in cancer treatment, and trained its psychologists to specialize in issues specific to people with cancer.

<span class="mw-page-title-main">Thomas Hutson</span> American oncologist and cancer researcher

Thomas E. Hutson is an American medical oncologist and cancer researcher based in Dallas, Texas. He is the director of Genitourinary Oncology Program and co-director of the Urologic Cancer Research and Treatment Center at Baylor University Medical Center. He is a Professor of Medicine at the Texas A&M Health Science Center College of Medicine and serves as a chair of Genitourinary Research for US Oncology and McKesson.

<span class="mw-page-title-main">Sandra M. Swain</span> American oncologist

Sandra M. Swain is an American oncologist, breast cancer specialist and clinical translational researcher. She is currently a professor of Medicine at the Georgetown University School of Medicine and the Associate Dean for Research Development at Georgetown University Medical Center (GUMC) and MedStar Health as well as an adjunct professor of Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of Health Sciences. She is also a past President of the American Society of Clinical Oncology (ASCO), serving from 2012 through 2013.

<span class="mw-page-title-main">Toni Choueiri</span> American medical oncologist

Toni K. Choueiri is a Lebanese American medical oncologist and researcher. He is the Jerome and Nancy Kohlberg Professor of Medicine at Harvard Medical School and Director of the Lank Center for Genitourinary Oncology at the Dana–Farber Cancer Institute. His work has led to the establishment of several novel drugs and prognostic factors in advanced renal cell carcinoma (RCC). Choueiri also co-established the International metastatic database Consortium with Daniel Heng. His biomarker work has shed light on complex immunogenomics mechanisms contributing to response and resistance to targeted therapy and immunotherapy.

Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radiosensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.

Stephanie Lynn Schutt Graff is an American breast medical oncologist. She is the Director of Breast Oncology at the Lifespan Cancer Institute and an Assistant Professor of Medicine at Alpert Medical School. Previously she was the Director of both the Breast Program and Clinical Research at Sarah Cannon Research Institute at HCA Midwest Health at Sarah Cannon Research Institute and Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute.

Timothy Michael Pawlik is an American surgical oncologist. He is Chair of the Department of Surgery and the Urban Meyer III and Shelley Meyer Chair for Cancer Research at The Ohio State University and Surgeon-in-Chief at The Ohio State University Wexner Medical Center.

Elizabeth R. Plimack is an American medical oncologist. She is a professor in the Department of Hematology/Oncology and Chief of the Division of Genitourinary Medical Oncology at the Fox Chase Cancer Center. In these roles, she researches the treatment of genitourinary malignancies with a focus on bladder and kidney cancers.

Patrick J. Loehrer is an American oncologist who is Indiana University Distinguished Professor, Joseph W. and Jackie J. Cusick Professor in Oncology, Professor of medicine, Indiana University School of Medicine; Director emeritus, Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

References

  1. ↑ "Molecular Tumor Board". UK HealthCare. Retrieved December 23, 2023.
  2. ↑ Sartor, Oliver; Bono, Johann de; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (June 23, 2021). "Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer". New England Journal of Medicine. 385 (12): 1091–1103. doi: 10.1056/NEJMoa2107322 . PMC   8446332 . PMID   34161051.
  3. ↑ Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H. (May 20, 2021). "Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)". Journal of Clinical Oncology. 39 (18_suppl): LBA4. doi:10.1200/JCO.2021.39.15_suppl.LBA4. ISSN   0732-183X. S2CID   236400202.
  4. ↑ "Budget cuts could lead to more radon deaths". Newsweek. April 30, 2017. Retrieved May 3, 2017.
  5. ↑ "Myths About What Cancer Is and Cancer Causes | Reader's Digest". Reader's Digest. Retrieved May 3, 2017.
  6. ↑ Andersen, Charlotte (August 12, 2017). "50 Things Your Doctor Wishes You Knew About Losing Weight". rd.com. Retrieved August 12, 2017.
  7. ↑ Hilton, Charlotte; ersenDec 18. "Things You Can Do Today to Lose Weight". Reader's Digest. Retrieved January 5, 2019.{{cite web}}: CS1 maint: numeric names: authors list (link)
  8. ↑ Kowarski, Ilana (January 4, 2017). "5 Things to do before applying to medical school". U.S. News & World Report . Retrieved January 22, 2017.
  9. ↑ Murray, Brittany. "Cancer Prevention Month celebrated with decreased cancer rates". The Exponent Telegram. Retrieved May 3, 2017.
  10. ↑ "Med school requirements every healthcare hopeful should master in college" . Retrieved May 3, 2017.
  11. ↑ Skwarecki, Beth (February 10, 2017). "Unmatched after match day – What's Next?". Medscape . Retrieved February 10, 2017.
  12. ↑ "Chandler Park, MD, FACP". opmed.doximity.com. Retrieved October 5, 2019.
  13. ↑ "Doximity". doximity.com. Retrieved January 5, 2019.
  14. ↑ "Joint, Associate, & Adjunct Faculty — School of Medicine University of Louisville". louisville.edu. Retrieved April 6, 2021.
  15. ↑ "Advisory Deans — School of Medicine University of Louisville". louisville.edu. Retrieved April 6, 2021.
  16. ↑ "ASCO Faculty. Cme Information January 2018 1 » MOC". mocapp.asco.org. Retrieved April 6, 2021.
  17. ↑ "ASCO Faculty Cme Info 2019 Breast And Gynecologic Cancers » MOC". mocapp.asco.org. Retrieved April 6, 2021.
  18. ↑ "Faculty Cme Info 2019 Anticancer Therapeutics Research And Supportive Care » MOC". mocapp.asco.org. Retrieved April 6, 2021.
  19. ↑ "ASCO Faculty Cme Info 2020 Self Evaluation App Hematologic Malignancies » MOC". mocapp.asco.org. Retrieved April 6, 2021.
  20. ↑ "Developments in CAR T". Managed Healthcare Executive. Retrieved April 6, 2021.
  21. ↑ "Authors | Lung Cancer: Standards of Care | AccessHemOnc | McGraw-Hill Medical". hemonc.mhmedical.com. Retrieved April 6, 2021.
  22. ↑ Kloecker, Goetz; Fraig, Mostafa; Arnold, Susanne M.; Perez, Cesar A. (December 7, 2020). Lung Cancer: Standards of Care. ISBN   978-1260136203.
  23. ↑ "Park Discusses Targeted Therapy Trials in Intermediate- and High-Risk ccRCC". Targeted Oncology. Retrieved April 6, 2021.
  24. ↑ "Kentucky Society of Clinical Oncology Board of Trustees". kaomo.wildapricot.org. Retrieved August 15, 2020.
  25. ↑ "Advice for Patients with Advanced Renal Cell Carcinoma". Curetoday. October 25, 2023. Retrieved December 23, 2023.
  26. ↑ "Combination Immunotherapy for Treating Advanced Renal Cell Carcinoma". Curetoday. October 18, 2023. Retrieved December 23, 2023.
  27. ↑ "Recent Trial Updates in Advanced Renal Cell Carcinoma (RCC)". Targeted Oncology. March 31, 2023. Retrieved December 23, 2023.
  28. ↑ "Adjuvant Pembrolizumab in Patients with Clear-cell Renal Cell Carcinoma". Targeted Oncology. March 3, 2023. Retrieved December 23, 2023.
  29. ↑ "Dr. Park on the ARASENS and TITAN trials in mHSPC". Urology Times. April 14, 2023. Retrieved December 23, 2023.
  30. ↑ "Dr. Park on the Increasing Use of Biomarker Testing and Radiotheranostics in Prostate Cancer". OncLive. March 6, 2023. Retrieved December 23, 2023.
  31. ↑ "AR Pathway Inhibitors, ADCs, and IO/TKI Combinations Shape Standard Therapy in GU Cancers". OncLive. February 24, 2023. Retrieved December 23, 2023.
  32. ↑ "Dr Park on Navigating of Later-line Treatment Options in Metastatic Urothelial Carcinoma". OncLive. May 9, 2023. Retrieved December 23, 2023.
  33. ↑ Skwarecki, Beth (February 10, 2017). "Unmatched After Match Day – What's Next?". medscape.com.
  34. ↑ "Doximity Op-(m)ed". n.d.
  35. ↑ "Chandler Park | Freelance Journalist | Muck Rack". muckrack.com. Retrieved April 6, 2021.
  36. ↑ Park, Chandler (August 29, 2017). "How to Avoid being labeled a Problem Resident". opmed.doximity.com. Retrieved August 29, 2017.
  37. ↑ Park, Chandler (June 3, 2017). "Breaking News Coverage from ASCO". doximity.com. Retrieved June 3, 2017.
  38. ↑ Park, Chandler (December 13, 2017). "Practice-Changing Update for Newly Diagnosed Stage III or Stage IV Hodgkin's Lymphoma Patients". doximity.com. Retrieved December 13, 2017.
  39. ↑ "ASH 2018: Research That Will Make a Difference for Tomorrow's Oncologist". opmed.doximity.com. Retrieved January 5, 2019.
  40. ↑ "Hospital Practice". tandfonline.com. Retrieved May 3, 2017.
  41. ↑ "Cancervisit". cancervisit.com. Retrieved July 3, 2016.
  42. ↑ Fishburn, Whitney. "Matched, sorted: Tips to transition from student to resident". acpinternist.org. Retrieved April 6, 2021.
  43. ↑ "Chandler Park". IMDb. Retrieved April 6, 2021.
  44. ↑ Doximity Physician Spotlight: Dr. Chandler Park , retrieved April 6, 2021
  45. ↑ "2020 Kidney Cancer Update with Dr. Toni Choueiri at ESMO". opmed.doximity.com. Retrieved April 9, 2021.
  46. ↑ "2020 Prostate Cancer Update with Dr. Neeraj Agarwal". opmed.doximity.com. Retrieved April 9, 2021.
  47. ↑ "2020 Bladder Cancer Review with Dr. Petros Grivas: What Every Physician Should Know". opmed.doximity.com. Retrieved April 9, 2021.
  48. ↑ "Dr. Chandler Park at U.S. News & World Report". health.usnews.com. n.d. Retrieved July 3, 2016.
  49. ↑ University of Kentucky, Markey Cancer Center (n.d.). "Markey's Molecular Tumor Board thriving in its first year". ukhealthcare.uky.edu. Retrieved May 3, 2017.
  50. ↑ "Verification of Board Certifications". n.d.
  51. ↑ "Distinguished Physician of the American College of Physicians" (PDF). acponline.org. n.d. Retrieved July 3, 2016.
  52. ↑ "PET/CT and regional brain metabolic changes associated with depression in metastatic breast cancer. (presented at 2016 ASCO Annual Meeting)". ASCO University. Retrieved July 3, 2016.
  53. ↑ Park, Chandler; Perini, Jessica; Farmer, Roger W; Fancy, Tanya; Monga, Manish; Remick, Scot C (2014). "Expert Review Medical Journal: Sorafenib and Thyroid Cancer". Expert Review of Endocrinology & Metabolism. 9 (6): 561–570. doi:10.1586/17446651.2014.960391. PMID   30736194. S2CID   56683794.
  54. ↑ "Pemetrexed and Non Small Cell Lung Cancer at 2015 American Society of Clinical Oncology Research Papers". asco.org.
  55. ↑ Adcock, Amelia; Park, Chandler; Gyure, Kymberly; Bittner, Frank; Murray, Ann (April 6, 2015). "Atypical Neurolymphomatosis: How to treat". Neurology. 84 (14 Supplement): 2.012.
  56. ↑ "Metformin use and allogeneic stem cell transplant (ASCT) outcomes at 2015 American Society of Clinical Oncology Meeting". asco.org.
  57. ↑ Murray, Brittany (February 16, 2015). "Cancer Prevention Month celebrated with decreased cancer rates". The Exponent-Telegram . Retrieved January 22, 2017.
  58. ↑ "RSNA smorgasbord a delight. – Free Online Library". Thefreelibrary.com.
  59. ↑ "Study Shows Patient Comfort Systems MRI Pads Reduce Patient Motion and Exam Call-Backs : Innovative New TEMPUR Material (Developed by Tempur-Pedic Inc.) Enhances Patient Comfort According to Study to be Presented at RSNA 06" (PDF). Patientcomfortsystems.com.
  60. ↑ "Nicotine on bone blood flow". American Journal of Orthopedics. Archived from the original on August 15, 2016. Retrieved June 29, 2016.
  61. ↑ "Hospital Practice Editorial Board". www.tandfonline.com. Retrieved April 6, 2021.
  62. ↑ "MRI Viscoelastic Pads Presentation". RSNA.org.
  63. ↑ Park, Chandler (January 22, 2018). "Designing CPD That Improves Patient Care: Insights From a Practicing Oncologist". eventscribe.com. Retrieved January 22, 2018.
  64. ↑ Rowh, Mark (July 2, 2018). "Five Ways Health Execs Can Improve Lymphoma Treatment". managedhealthcareexecutive.com/non-hodgkin-lymphoma/five-ways-health-execs-can-improve-lymphoma-treatment. Retrieved July 2, 2018.
  65. ↑ "2020 Alliance Annual Conference". www.eventscribe.com. Retrieved April 6, 2021.
  66. ↑ "Advances in Cancer Immunotherapy | Louisville". www.sitcancer.org. Retrieved April 9, 2021.
  67. ↑ "Search Top Doctors. Find Trusted Care". Castle Connolly. Retrieved April 9, 2021.
  68. ↑ "Dr. Chandler H. Park - Medical Oncology - Castle Connolly Top Doctor". Castle Connolly. Retrieved April 6, 2021.
  69. ↑ "Castle Connolly Top Doctor in 2020". www.americanregistry.com. Retrieved April 9, 2021.
  70. ↑ "Castle Connolly Top Doctor in 2021". www.americanregistry.com. Retrieved April 9, 2021.
  71. ↑ "3 Best Oncologists in Louisville, KY - Expert Recommendations". ThreeBestRated.com. Retrieved April 9, 2021.
  72. ↑ "Patients Choice Award". www.americanregistry.com. Retrieved April 6, 2021.
  73. ↑ "Compassionate Doctor Award". www.americanregistry.com. Retrieved April 6, 2021.
  74. ↑ "Kentucky's Favorite Doctors". www.americanregistry.com. Retrieved April 6, 2021.
  75. ↑ "Top 1% of Doctors". www.americanregistry.com. Retrieved April 6, 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.